The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder

HIGHLIGHTS

• who: Qingyang Li from the Participants The ASD participants were recruited from the Shanghai Xinhua ASD registry at Shanghai Jiaotong University Medical School Affiliated Xinhua Hospital in Shanghai, China, including the participants from two previous registered clinical studies, ie., CHICtr-, and NCT03156153. The patients were diagnosed with ASD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnoses were confirmed with the Autism Diagnostic Observation Schedule (ADOS), and a Children Autism Rating Scale (CARS) total score of no less than, . Exclusion criteria include liver and kidney dysfunction have published the article: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.